Novick Bio-Sciences Profile
Key Indicators
- Authorised Capital ₹ 14.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 14.03 Cr
as on 16-11-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 Cr
as on 16-11-2024
- Revenue 19.42%
(FY 2023)
- Profit 139.31%
(FY 2023)
- Ebitda 143.21%
(FY 2023)
- Net Worth 23.89%
(FY 2023)
- Total Assets 60.30%
(FY 2023)
About Novick Bio-Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.50 Cr and a paid-up capital of Rs 14.03 Cr.
The company currently has active open charges totaling ₹6.00 Cr.
The Key Managerial Personnel (KMP) at Novick Bio-Sciences Private Limited India is Venkata Konda as COMPANY SECRETARY. Srinivasa Kumar and Vinayak Dendukuri serve as directors at the Company.
- CIN/LLPIN
U74999TG2016PTC112022
- Company No.
112022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Novick Bio-Sciences Private Limited offer?
Novick Bio-Sciences Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Novick Bio-Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Konda | Company Secretary | 01-Mar-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Kumar  | Director | 08-Aug-2018 | Current |
| Vinayak Dendukuri | Director | 19-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Novick Bio-Sciences.
Novick Bio-Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.42% increase. The company also saw a substantial improvement in profitability, with a 139.31% increase in profit. The company's net worth Soared by an impressive increase of 23.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novick Bio-Sciences?
In 2023, Novick Bio-Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sarvoch Mines & Infrastructure Private LimitedActive 15 years 9 months
Srinivasa Kumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 03 Mar 2022 | ₹6.00 Cr | Open |
How Many Employees Work at Novick Bio-Sciences?
Novick Bio-Sciences has a workforce of 76 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novick Bio-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novick Bio-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
